RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines

/PRNewswire/ -- RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based...

Related Keywords

China ,California ,United States ,Gaithersburg ,Maryland ,Dong Shen ,Zhejiang ,Seychelles ,Republic Of Seychelles ,Nigel Yip ,Los Angeles ,Bunny Lee ,Alexis Feinberg ,Patrick Lu ,Rnaimmune Inc ,University Of California ,Drug Administration ,Sirnaomics Ltd ,River Limited Smooth ,Boulder Fund ,University Of Houston ,Smooth River Limited ,Rotating Boulder ,Executive Director ,Chief Executive Officer ,Series Seed ,Rotating Boulder Fund ,Polypeptide Lipid Nanoparticle ,Media Contact ,